At Servier we continue to foster the ambition to provide innovative therapies for unmet medical needs for the benefit of patients. In order to succeed in this exciting challenge we are actively developing our expertise and teams in our therapeutic areas.
In this aim, we are currently seeking the opportunity to recruit a
Drug Discovery Project Leader in Neuropsychiatry
We are looking for a highly-motivated scientific leader with skills in project management and the ability to translate emerging scientific knowledge on Proteinopathies into novel drug candidates for the improved treatment of Alzheimer’s, Parkinson’s and other neurodegenerative diseases.
Working in the Neuropsychiatry Department, you will lead a dedicated project either derived from internal programs, or sourced from outside institutions. You will coordinate multidisciplinary work with internal and external partners from the phase of target validation through to the proposition of preclinical candidates.
Your mission, mirroring our “R and D” working spirit, will be articulated around the principles of Entrepreneurship, Collaboration, Performance and Communication.
D. and Post-Doc in Neuroscience: Expertise in the fields of Proteinopathies and Neurodegenerative disorders of the CNS.
2-5 years’ experience after your PhD, preferably involving a drug discovery-related position in a Biotech or Pharmaceutical company.
Strong organizational skills and the ability to design and run a unique project.
Excellent interpersonal relations and a well-developed sense of team-work.
Perfectly fluent in English - French would be a plus.
About Servier Neuropsychiatry Innovation Therapeutic Unit
Together with international experts, for over 30 years we have been investing in programs to improve the control of neuropsychiatric and neurodegenerative diseases like Alzheimer’s, Parkinson’s, multiple sclerosis and depression.
The Servier’s Neuropsychiatry Innovation Therapeutic Unit accommodates an in vivo platform as a part of its experimental research, located near Paris, in Croissy-sur-Seine, France. This platform is involved in early drug development and is strongly oriented towards providing rodent models to screen compounds intended for neurodegenerative diseases.
Joining Servier means working in a stimulating environment and contributing to an innovative, research-based and people-oriented organization.
Servier is the leading French independent pharmaceutical company, located in 146 countries with 21 400 employees and a turnover in 2016 of about 4 billion euros.
25% of Servier’s annual turnover is reinvested in Research & Development, reflecting the company’s dedication to its mission of innovation and discovery for improved treatment of unmet medical needs.
Organized as a foundation, we guarantee our independence toward stock exchange market. Our founder Doctor Jacques Servier used to say: “a company is a group of human beings, so it has no price”.
Servier is well known for staff care, with particular attention to career evolution within the Group, and to an agreeable and productive working environment.